The following represents disclosure information provided by authors of this abstract. The program committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered compensated. Relationships are self-held unless otherwise noted. I = Immediate Family Member, Inst = My Institution
 
Open Payments is a public database containing information reported by companies about payments made to US-licensed physicians (Open Payments)
A phase I clinical trial on intratumoral and intracavitary administration of ipilimumab and nivolumab in patients with recurrent glioblastoma.
 
Julia Katharina Schwarze
Travel, Accommodations, Expenses - Amgen; MSD
 
Johnny Duerinck
No Relationships to Disclose
 
Ines Dufait
No Relationships to Disclose
 
Gil Awada
Employment - Abbott Laboratories (I)
Consulting or Advisory Role - Novartis
Research Funding - Novartis (Inst); Pfizer (Inst)
Travel, Accommodations, Expenses - Astellas Pharma; MSD Oncology; Novartis; Pfizer
 
Samuel Klein
No Relationships to Disclose
 
Lydia Fischbuch
No Relationships to Disclose
 
Laura Seynaeve
No Relationships to Disclose
 
Freya Vaeyens
No Relationships to Disclose
 
Anne Rogiers
Consulting or Advisory Role - Bristol-Myers Squibb
Travel, Accommodations, Expenses - MSD
 
Hendrik Everaert
No Relationships to Disclose
 
Anne-Marie Vanbinst
No Relationships to Disclose
 
Alex Michotte
No Relationships to Disclose
 
Bart Neyns
Honoraria - Bristol-Myers Squibb; Merck Sharp & Dohme; Novartis; Roche
Consulting or Advisory Role - Amgen; Bristol-Myers Squibb; Merck Sharp & Dohme; Novartis; Pfizer/EMD Serono; Roche; Sanofi
Speakers' Bureau - Novartis
Research Funding - Merck KGaA (Inst); Novartis (Inst); Pfizer (Inst)
Travel, Accommodations, Expenses - Amgen; Bristol-Myers Squibb; Merck Sharp & Dohme; Novartis; Roche